# Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

> **NCT00390364** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** everolimus
- **PROCEDURE:** antiangiogenesis therapy
- **PROCEDURE:** biopsy
- **PROCEDURE:** diagnostic procedure
- **PROCEDURE:** gene expression analysis
- **PROCEDURE:** immunohistochemistry staining method
- **PROCEDURE:** laboratory biomarker analysis
- **PROCEDURE:** mutation analysis
- **PROCEDURE:** protein tyrosine kinase inhibitor therapy
- **PROCEDURE:** reverse transcriptase-polymerase chain reaction

## Key facts

- **NCT ID:** NCT00390364
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Withdrawn due to low accrual
- **Last updated:** 2014-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390364, "Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00390364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*